Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERIT: ALK House Dust Mite Tablet in Allergic Rhinitis
NCT01454544Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Oct 2011
- Primary completion
- Apr 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SQ SLIT-tablet in allergic rhinitis (AR), sponsored by ALK-Abelló. Started Oct 2011; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01454544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454544.